Palomino Laboratories (PALX) Notes Payables (2022 - 2025)

Palomino Laboratories (PALX) has 4 years of Notes Payables data on file, last reported at $318750.0 in Q3 2025.

• For the quarter ending Q3 2025, Notes Payables rose 144.73% year-over-year to $318750.0; the trailing twelve-month figure through Sep 2025 stood at $318750.0 (up 144.73% YoY), and the FY2024 full-year result was $3140.0, down 96.05% from the prior year.
• Notes Payables climbed to $318750.0 in Q3 2025, from $20000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $318750.0 in Q3 2025 to a low of $304.0 in Q4 2022.
• A 4-year average of $103956.8 and a median of $79563.0 in 2023 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables soared 26072.04% in 2023 and plunged 96.05% in 2024, its largest moves.
• Tracing PALX's Notes Payables over 4 years: stood at $304.0 in 2022, then soared by 26072.04% to $79563.0 in 2023, then sank by 96.05% to $3140.0 in 2024, then soared by 10051.27% to $318750.0 in 2025.
• Business Quant data shows PALX's Notes Payables at $318750.0 in Q3 2025, $20000.0 in Q2 2025, and $275000.0 in Q1 2025.